Campaign with us
With your support, we can make sure people living with dementia and research into the condition remain a national priority.
Lend Your Voice
It doesn’t take long to make an impact. How much time can you give?
Help us spread the word.
Join us on social media and tell others about the important work we’re doing. You can find our logo, banners, graphics and videos in our Campaigner toolkit.
Sign up for Campaigner emails.
Each month you’ll receive a newsflash with the top stories impacting dementia and how you can get involved. Just fill out this form and you’re on your way.
Write to your MP.
Let your MP know why dementia research is important to you. We’ve done some of the work for you. Check the toolkit for letter templates to get started.
“I really wanted to do something that would make a difference to those affected by dementia, but as I’m not a scientist I needed to find something else. Being a Campaigner means I can raise awareness of the need to invest in research with the people who have the power to bring about change.
“Seeing the progress you can make as a Campaigner is definitely the best part, it felt like a real achievement when I organised the lab tour with my MP. I’d encourage anyone thinking about becoming a Campaigner to sign up. If we don’t do it, who will?”
“In 2015 I lost my wonderful Dad to Alzheimer’s after he put up a tremendous fight. It was so sad to see him withdraw from the incredible and outgoing character he was.
“I vowed at the time to do my part in helping to eradicate this dreadful disease for future generations and Alzheimer’s Research UK was an obvious and worthwhile choice.
“After I wrote my MP Andrew Mitchell, he dropped me a letter to say he was going to address the matter. I then had a note from Alzheimer’s Research UK to say how helpful Mr Mitchell had been – I was hugely impressed with how simple the process was and the impact achieved.
“Campaigning is so easy to do and I believe that raising the charity profile within government will ensure that much needed funds are allocated for both research and care of people with the disease.”